BR

Bibha Rai

Active Director Director DIN 10286540
DIN 10286540 First appointment Aug 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Aug 2023
Shareholding value Locked Premium profile

About Bibha Rai

Bibha Rai has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Zenthomed Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10286540
Primary Designation Director
First Appointment 21 Aug 2023
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Zenthomed Pharma Private Limited U52609MH2021PTC360305
Director 21 Aug 2023 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zenthomed Pharma Private Limited
Premium access

Shareholding and investment profile for Bibha Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bibha Rai

Bibha Rai has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Zenthomed Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Bibha Rai is associated with 1 company as Director.

Bibha Rai has expertise in General Business.

Bibha Rai has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available